Zosano Pharma Corporation
ZSAN
ZSAN was delisted on the 10th of June, 2022.
16 hedge funds and large institutions have $46.1M invested in Zosano Pharma Corporation in 2015 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 3 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
16% less funds holding
Funds holding: 19 → 16 (-3)
29% less capital invested
Capital invested by funds: $64.9M → $46.1M (-$18.8M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$581K |
| 2 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
+$476K |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$439K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$278K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$30.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.08M |
| 2 |
RA
Royce & Associates
New York
|
-$910K |
| 3 |
VAM
Visium Asset Management
New York
|
-$223K |
| 4 |
Morgan Stanley
New York
|
-$143K |
| 5 |
Millennium Management
New York
|
-$142K |
ZSAN Hedge Fund Activity: Q2 2015 in Review
16 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Zosano Pharma Corporation (ZSAN) for Q2 2015, worth a combined $46.1M — down 29% from $64.9M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ZSAN and 0 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 5 added.
The largest buyer was Acuta Capital Partners, adding an estimated $581K. The largest seller was Sphera Funds Management, cutting an estimated $1.08M.
- 16 institutional investors held Zosano Pharma Corporation (ZSAN) as of Q2 2015, down from 19 in Q1 2015.
- Funds reported $46.1M of Zosano Pharma Corporation stock for Q2 2015, down 29% quarter-over-quarter.
- 0 funds opened new Zosano Pharma Corporation positions in Q2 2015 and 3 closed out, a net change of -3 holders.
- The largest Zosano Pharma Corporation buyer in Q2 2015 was Acuta Capital Partners, an estimated $581K added.
- The largest Zosano Pharma Corporation seller in Q2 2015 was Sphera Funds Management, an estimated $1.08M sold.
Based on aggregated 13F filings for Q2 2015.